pituitary adenylate cyclase-activating polypeptide-38

Peptideexperimental

Clinical trial activity

10 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 2006 (NCT00380263)

Timeline

2010s

  1. Jan 1, 2015

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Multi-specific
No

Oral

No

Parenteral

No

Topical

No

Also known as

  • pacap
  • pituitary adenylate cyclase-activating polypeptide
  • pituitary adenylate cyclase-activating polypeptide
  • pituitary adenylate cyclase-activating polypeptide-38
  • pituitary adenylate cyclase-activating polypeptide-38

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05635604N/ADec 1, 2022University of Copenhagen
NCT05378061N/AJun 16, 2022University of Copenhagen
NCT04960657N/AOct 20, 2020University of Copenhagen
NCT03881644N/AJul 17, 2018University of Copenhagen
NCT03814226N/AJan 1, 2018University of Copenhagen
NCT02542605Phase 1Nov 11, 2015Amgen
NCT02364453N/AFeb 1, 2015Danish Headache Center, University of Copenhagen
NCT02158221N/AJun 1, 2014University of Copenhagen
NCT01471990N/AMay 1, 2011Cool Sorption Foundation of 1988, Lundbeck, University of Copenhagen
NCT00380263N/ANov 1, 2006University of Copenhagen
Showing 10 of 10 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of CopenhagenAcademic/Hospital9812006
AmgenFor profit1112015
Cool Sorption Foundation of 1988Academic/Hospital1012011
Danish Headache CenterAcademic/Hospital1112015
LundbeckFor profit1012011
5 organizations
Page 1 / 1